ASH 2023 top abstract lists from across the SES educational hubs
December 20, 2023
To help navigate the exciting content presented at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition, the hub steering committee members provided their recommendations for the top abstracts to look out for in their respective therapy areas. Our teams have compiled these abstracts into easy-to-navigate, digestible lists which assist healthcare professionals in finding content that is most relevant to them.
- Frontline and emerging therapies for ALL
- Treatment for relapsed/refractory ALL
- Allogeneic transplantation
- Real-world evidence
- Socioeconomic challenges
- Molecular biomarkers
- Treatment-related toxicities
- Download the ALL Hub Top Abstract list HERE
- Early phase trials
- Late phase trials
- Real-world, registry, and observational studies
- Classification systems
- Older patients
- Biomarkers
- Translational research
Download the AML Hub Top Abstract list HERE
- GvHD prophylaxis and early phase trials
- Late phase trials
- Novel therapies
- Risk stratification
- Advances in disease biology and clinical trial methodology
Download the GvHD Hub Top Abstract list HERE
Top abstracts in lymphoma and CLL
- Indolent and mantle cell non-Hodgkin’s lymphoma
- Hodgkin's lymphoma
- T-cell lymphoma
- Aggressive B-cell non-Hodgkin lymphoma
- Chronic lymphocytic leukemia
- Advances in disease biology
Download the Lymphoma Hub Top Abstract list HERE
Top abstracts in MM and other plasma cell dyscrasias
- Newly diagnosed multiple myeloma
- Relapsed and/or refractory multiple myeloma
- Other plasma cell dyscrasias
Top abstracts by region
- Latin America
- Asia Pacific
- Europe, the Middle East, and Africa
Download the Multiple Myeloma Hub Top Abstract list HERE
Find all the top abstracts in MPN for each day of the ASH Annual Meeting and Exposition, download the MPN Hub Top Abstract list HERE.
